Cidara Therapeutics Announces First Subjects Dosed in Phase 2B Navigate Trial Evaluating Cd388 for the Prevention of Seasonal Influenza
cidara therapeutics宣佈,20億多食管試驗中首批受試者接受了CD388,用於預防季節性流感。
Cidara Therapeutics Announces First Subjects Dosed in Phase 2B Navigate Trial Evaluating Cd388 for the Prevention of Seasonal Influenza
cidara therapeutics宣佈,20億多食管試驗中首批受試者接受了CD388,用於預防季節性流感。
譯文內容由第三人軟體翻譯。